You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


Community Considerations: Expanding the Utility of Immunotherapy in Patients With Non–Small Cell Lung Cancer

  • Authors: Julie Brahmer, MD, MSc, FASCO
  • CME / ABIM MOC Released: 2/28/2023
  • Valid for credit through: 2/28/2024
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for oncologists, pathologists, surgeons, pulmonologists, and other members of the NSCLC multidisciplinary care team.

The goal of this activity is for learners to be better able to improve their understanding of the immunotherapy treatment strategies used throughout the spectrum of patients with NSCLC and to individualize care for these patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Recent clinical trial data evaluating immunotherapy-containing regimens for the management of patients with NSCLC
  • Have greater competence related to
    • Identifying patients with NSCLC who are eligible for treatment with immunotherapy

    • Tailoring treatment decisions for patients with NSCLC who are eligible for immunotherapy
  • Demonstrate greater confidence in their ability to
    • Integrate evolving immunotherapy data into the care of patients with NSCLC


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


  • Julie Brahmer, MD, MSc, FASCO

    Professor of Oncology
    Johns Hopkins University
    Upper Aerodigestive Department
    Bloomberg-Kimmel Institute for Cancer Immunotherapy
    Baltimore, Maryland


    ​​Participation by Dr ​Brahmer​ does not constitute or imply endorsement by the Johns Hopkins University or the Johns Hopkins Hospital and Health System. 

    Julie Brahmer, MD, MSc, FASCO, has the following relevant financial relationships:
    Consultant or advisor for: Amgen Inc.; AstraZeneca; Blueprint Medicines Corporation; Bristol-Myers Squibb; Eisai, Inc.; Eli Lilly and Company; Genentech/Roche; Incyte Corporation; Janssen Pharmaceuticals; Johnson & Johnson; Merck & Co., Inc; Regeneron Pharmaceuticals; Sanofi
    Speaker or member of speakers bureau for: Janssen Pharmaceuticals (CME speaker)
    Research funding from: AstraZeneca; Bristol-Myers Squibb; RAPT Therapeutics; Revolution Medicine; Spectrum Pharmaceuticals


  • Amy Furedy, RN, OCN

    Medical Education Director, Medscape, LLC


    Amy Furedy, RN, OCN, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


Community Considerations: Expanding the Utility of Immunotherapy in Patients With Non–Small Cell Lung Cancer

Authors: Julie Brahmer, MD, MSc, FASCOFaculty and Disclosures

CME / ABIM MOC Released: 2/28/2023

Valid for credit through: 2/28/2024


A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print